AAO 2014 in Chicago will feature four Governmental Affairs sessions that showcase the relationship between the Academy and federal agencies and lawmakers. Academy members are encouraged to mark their calendars to take advantage of these timely sessions. All events are free.
Parker Heath Lecture by Sen. Rand Paul, MD
Part of the 2014 AMA Ophthalmology Section Council Symposium (SYM 22)
Monday, Oct. 20, 8:30-10 a.m.
McCormick Place, S406A
Sen. Rand H. Paul, MD, R-Ky., will present this year's Parker Heath Lecture during a free symposium on the Affordable Care Act. The only ophthalmologist currently serving in Congress, Dr. Paul has championed ophthalmology priorities such as repeal of the sustainable growth rate; preserving office-use access to compounded drugs; and derailing problematic quality measures for ASCs. Dr. Paul also serves on the Senate Health, Education, Labor and Pensions Committee. Don't miss this special chance to hear his views on health care.
Each year, the Parker Heath lecture is presented during a combined meeting with the American Medical Association Ophthalmology Section Council. This year's meeting looks at how the ACA will continue to impact ophthalmology practices in many ways and at different levels. These include the addition of more patients now covered by insurance, the expansion of Medicaid, new individual insurance mandates, and new insurance exchanges for comparison shopping.
The ACA also imposes new regulations on medical practices as business entities, as well as changes in the health insurance environment, with accountable care organizations that may manage a continuum of a patient’s care across different settings. The ACA created the federal center for Medicare and Medicaid Innovation, which may result in new payment methodologies such as bundled payments for services. The speakers will provide insight on how ophthalmologists should respond to these changes.
2015 Medicare Update (SPE11)
Sunday, Oct. 19, 12:15-1:15 p.m.
McCormick Place, Grand Ballroom S100C
Details to come.
Q&A with the FDA (SPE13)
Sunday, Oct. 19, 12:45-1:45 p.m.
McCormick Place, N427D
Have questions about the drug and device approval process? Want to talk about new FDA initiatives? Need answers about the latest news affecting ophthalmic products? Join FDA ophthalmic drug and device experts for a session with a new format driven entirely by you. Submit your questions to the Academy and FDA experts will give you the information you need to know!
Visual Impact of Traumatic Brain Injury: Lessons Learned (SPE18)
Monday, Oct. 20, 12:45-1:45 p.m.
McCormick Place, S102ABC
Traumatic Brain Injury (TBI) has become a significant focus in VA, DOD, and the private sector due to severe blast injuries, vehicular accidents, football and other sports-related injuries. Neurotrauma exhibits diverse clinical presentations often requiring complex coordination of care. Topics for discussion include ocular and visual outcomes, mechanisms of injury and the integrated multidisciplinary approach of the TBI patient. Speakers will also discuss the nature of TBI spectrum including assessment and management. A question and answer period will follow.